Marion Wealth Management Increases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Marion Wealth Management lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,917 shares of the healthcare conglomerate’s stock after purchasing an additional 656 shares during the period. Marion Wealth Management’s holdings in UnitedHealth Group were worth $3,099,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Waycross Partners LLC increased its position in shares of UnitedHealth Group by 2.4% during the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock worth $14,060,000 after purchasing an additional 658 shares in the last quarter. Sherbrooke Park Advisers LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $515,000. Full Sail Capital LLC increased its holdings in shares of UnitedHealth Group by 2.1% in the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock valued at $815,000 after purchasing an additional 33 shares during the period. Soros Fund Management LLC purchased a new position in UnitedHealth Group in the 4th quarter valued at $39,413,000. Finally, Silvercrest Asset Management Group LLC raised its position in UnitedHealth Group by 47.8% during the 4th quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate’s stock worth $19,625,000 after buying an additional 12,550 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insiders Place Their Bets

In related news, CFO John F. Rex bought 17,175 shares of the stock in a transaction dated Friday, May 16th. The stock was acquired at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the purchase, the chief financial officer now owns 203,796 shares in the company, valued at $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Kristen Gil bought 3,700 shares of the stock in a transaction dated Thursday, May 15th. The stock was bought at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the purchase, the director now owns 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders bought 109,408 shares of company stock worth $31,607,768 over the last three months. 0.33% of the stock is owned by insiders.

UnitedHealth Group Stock Performance

NYSE UNH opened at $301.08 on Friday. The business’s 50-day moving average price is $430.87 and its 200 day moving average price is $494.23. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The company has a market capitalization of $273.12 billion, a PE ratio of 19.42, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the prior year, the company earned $6.91 earnings per share. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts recently issued reports on the stock. Erste Group Bank cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. Robert W. Baird decreased their price target on UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 14th. Mizuho reduced their target price on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a report on Friday, May 16th. Raymond James downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a report on Wednesday, May 14th. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on shares of UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating on the stock in a research report on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $441.87.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.